Identification of benzene metabolites in dermal fibroblasts as nonphenolic: Regulation of cell viability, apoptosis, lipid peroxidation and expression of matrix metalloproteinase 1 and elastin by benzene metabolites

Skin Pharmacology and Physiology

Volumn 17, Issue 3, 2004, Pages 147-152

  Philips, N ^a   Burchill, D ^a   O'Donoghue, D ^a   Keller, T ^a   Gonzalez, S ^b  

^a Biology and Chemistry/Biochemistry   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Aniline; Benzaldehyde; Benzoic acid; Hydrogen peroxide; Hydroquinone; Phenol; t Butyl hydroquinone; Toluene

Indexed keywords

ANILINE; BENZALDEHYDE; BENZENE; BENZOIC ACID; ELASTIN; HYDROGEN PEROXIDE; HYDROQUINONE DERIVATIVE; INTERSTITIAL COLLAGENASE; PHENOL; TERT BUTYLHYDROQUINONE; TOLUENE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CIGARETTE SMOKING; DRUG EXPOSURE; DRUG IDENTIFICATION; DRUG METABOLISM; FIBROBLAST; HUMAN; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ANILINE COMPOUNDS; APOPTOSIS; BENZALDEHYDES; BENZENE; BENZENE DERIVATIVES; BENZOIC ACID; CELL SURVIVAL; DERMIS; ELASTIN; FIBROBLASTS; HYDROGEN PEROXIDE; HYDROQUINONES; LIPID PEROXIDATION; MATRIX METALLOPROTEINASE 1; PHENOL; TOLUENE;

EID: 1842678419     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077242     Document Type: Article

References (37)

1. Vojdani A, Mordechai E, Brautbar N: Abnormal apoptosis and cell cycle progression in humans exposed to methyl tertiary-butyl ether and benzene contaminated water. Hum Exp Toxicol 1997;16:485-494.
2. Paustenbach DJ, Bass RD, Price P: Benzene toxicity and risk assessment, 1972-1992: Implications for future regulation. Environ Health Perspect 1993;101:117-200.
3. Gist GL, Burg JR: Benzene - A review of the literature from a health effects perspective. Toxicol Ind Health 1997;13:661-713.
4. Hiraku Y, Kawanishi S: Oxidative DNA damage and apoptosis induced by benzene metabolites. Cancer Res 1996;56:5172-5178.
5. Lewis JG, Stewart W, Adams DO: Role of oxygen radicals in induction of DNA damage by metabolites of benzene. Cancer Res 1988;48:4762-4765.
6. Joseph P, Klein-Szanto AJP, Jaiswal AK: Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis. Br J Cancer Res 1998;78:312-320.
7. Li Q, Aubrey MT, Christian T, Freed BM: Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydroquinone and catechol. Fundam Appl Toxicol 1997;38:158-165.
8. Rubin H: Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: A bio-historic perspective with updates. Carcinogenesis 2001;22:1903-1930.
9. Braier L: Anti-benzene compounds: Conversion of benzene to toluene by methyl donors, in man. Rev Bras Pesqui Med Biol 1977;10:319-323.
10. Braier L: Conversion of benzene to toluene by methyl donors in man. Nouv Rev Fr Hématol 1978;20:63-66.
11. Koh JS, Kang H, Choi SW, Kim HO: Cigarette smoking associated with premature facial wrinkling: Image analysis of facial skin replicas. Int J Dermatol 2002;41:21-27.
12. Kadunce DP, Burr R, Gress R, Kanner R, Lyon JL, Zone JJ: Cigarette smoking: Risk factor for premature facial wrinkling. Ann Intern Med 1991;114:840-844.
13. Giacomoni PU, Rein G: Factors of skin ageing share common mechanisms. Biogerontology 2001;2:219-229.
14. Seba BA: Dermatological manifestations of smoking. Harefuah 2002;141:736-740.
15. Pasquali-Ronchetti I, Baccarani-Contri M: Elastic fiber during development and aging. Microsc Res Tech 1997;38:428-435.
16. Moran JL, Siegel D, Sun X, Ross D: Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells. Mol Pharmacol 1996;50:610-615.
17. Seaton MJ, Schlosser PM, Bond JA, Medinsky MA: Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity. Carcinogenesis 1994;15:1799-1806.
18. Gut I, Nedelcheva V, Soucek P, Stopka P, Tichavska B: Cytochromes P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ Health Perspect 1996;104:1211-1218.
19. Turteltaub KW, Mani C: Benzene metabolism in rodents at doses relevant to human exposure from urban air. Res Rep Health Eff Inst 2003;113:1-35.
20. Lovern MR, Turner MJ, Meyer M, Kedderis GL, Bechtold WE, Schlosser PM: Identification of benzene oxide as a product of benzene metabolism by mouse, rat, and human liver microsomes. Carcinogenesis 1997;18:1695-1700.
21. Susten AS, Niemeier RW, Simon SD: In vivo percutaneous absorption studies of volatile organic solvents in hairless mice. II. Toluene, ethylbenzene and aniline. J Appl Toxicol 1990;10:217-225.
22. Blank IH, McAuliffe DJ: Penetration of benzene through human skin. J Invest Dermatol 1985;85:522-526.
23. McDougal JN, Jepson GW, Clewell HJ, Gargas ML, Andersen ME: Dermal absorption of organic chemical vapours in rats and humans. Fundam Appl Toxicol 1990;14:299-308.
24. Morgan DL, Cooper SW, Carlock DL, Sykora JJ, Sutton B, Mattie DR, McDougal JN: Dermal absorption of neat and aqueous volatile organic chemicals in the Fisher 344 rat. Environ Res 1991;55:51-63.
25. Moody RP, Nadeau B: An automated in vitro dermal absorption procedure. III. In vivo and in vitro comparison with the insect repellent N,N-diethyl-m-toluamide in mouse, rat, guinea pig, pig, human and tissue-cultured skin. Toxicol In Vitro 1993;7:167-176.
26. Nakai JS, Chu I, Li-Muller A, Aucoin R: Effect of environmental conditions on the penetration of benzene through human skin. J Toxicol Environ Health 1997;51:447-462.
27. Kalnas J, Teitelbaum DT: Dermal absorption of benzene: Implications for work practices and regulations. Int J Occup Environ Health 2000;6:114-121.
28. Hanke J, Dutkiewicz T, Piotrowski J: The absorption of benzene through human skin. Int J Occup Environ Health 2000;6:104-111.
29. Franz TJ: Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol 1975;64:190-195.
30. Kao J, Carver MP: Cutaneous metabolism of xenobiotics. Drug Met Rev 1990;22:363-410.
31. Pannatier A, Jenner P, Testa B, Etter JC: The skin as a drug-metabolizing organ. Drug Met Rev 1978;8:319-343.
32. Merk H, Jugert F, Bonnekoh B, Mahrle G: Induction and inhibition of NAD(P)H: Quinone reductase in murine and human skin. Skin Pharmacol 1991;4:183-190.
33. Jugert FK, Agarwal R, Kuhn A, Bickers DR, Merk HF, Mukhtar H: Multiple cytochrome P450 isozymes in murine skin: Induction of P450 1A, 2B, 2E, and 3A by dexamethasone. J Invest Dermatol 1994;102:970-975.
34. Ahmad N, Agarwal R, Mukhtar H: Cytochrome P-450 and drug development for skin diseases. Skin Pharmacol 1996;9:231-241.
35. 3 or UVB radiation in keratinocytes of human skin equivalents - A preliminary study. Arch Dermatol Res 1999;291:507-510.
36. Flesher JW, Myers SR: Methyl-substitution of benzene and toluene in preparations of human bone marrow. Life Sci 1991;48:843-850.
37. Ghantous H, Dencker L, Gabrielsson J, Danielsson BR, Bergman K: Accumulation and turnover of metabolites of toluene and xylene in nasal mucosa and olfactory bulb in the mouse. Pharmacol Toxicol 1990;66:87-92.